The pooled results were not significant changed for random effects model (OR = 3.76, 95% CI: 2.30–6.15, P < 0.05), indicating that patients with hypermethylated MGMT may have an increased risk in breast and gynecological cancers. This evidence concerns the gene MGMT and female reproductive organ cancer.